Recombinant Human Suppression Of Tumorigenicity 14 (ST14) RPU43922 from Biomatik | Biocompare.com

Supplier Images

Recombinant Human Suppression Of Tumorigenicity 14 (ST14)

Be the first to write a review!

Supplier Page from
Biomatik for
Recombinant Human Suppression Of Tumorigenicity 14 (ST14)

Description

Recombinant Human Suppression Of Tumorigenicity 14 (ST14) is a purified Prokaryotic Protein

Product Specs
ItemRecombinant Human Suppression Of Tumorigenicity 14 (ST14)
CompanyBiomatik
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberRPU43922
Quantity100ug
ApplicationsPositive Control, Immunogen, SDS-PAGE, WB
Conjugate/TagN-terminal His Tag, Unconjugated
Purity>97% by SDS-PAGE
Molecular Weight33kDa
SpeciesHuman (Homo sapiens)
Source/Expression SystemProkaryotic Expression
E. coli
Gene NameSuppression Of Tumorigenicity 14 (ST14)
Research AreaTumor Immunity
Brand/TrademarkBiomatik Corporation
TypeProkaryotic Protein
Storage-20°C. Avoid repeated freeze/thaw cycles
ActivityNot Tested
ProteinSuppression Of Tumorigenicity 14 (ST14)
FormatPBS, pH7.4, containing 0.01% SKL, 5% Trehalose
Domain/Region/TerminusArg607~Asn852
NCBI Full Gene NameST14 transmembrane serine protease matriptase
NCBI Gene AliasesMT-SP1, HAI, PRSS14, CAP3, TADG15, SNC19, TMPRSS14, ARCI11, MTSP1

Add to Compare List

Biomatik

Local Office

Biomatik

105-501 Silverside Road

Wilmington, Delaware 19809

United States

Phone: 1-800-836-8089
Fax: 1-877-221-3515

Company Profile

Website: www.biomatik.com

International Office

Biomatik

4 Third Ave

Kitchener, Ontario N2C 1N6

Canada

Phone: 1-800-836-8089 (USA/Canada)
1-519-489-7195 (International)
Fax: 1-877-221-3515 (USA/Canada)
1-519-231-0140 (International)

Company Profile

Website: www.biomatik.com

Be the First to Write a Review!